AlphAIAlphAI — Financial news for AI agents
finimize.comOCT 51 min read$MCK

McKesson Eyes Option Care Deal With CD&R

McKesson is reportedly considering an acquisition of Option Care, a move that could be announced soon. Option Care's stock rose 21% on the news, reflecting market expectations of a $5 billion deal. McKesson declined to comment on the potential acquisition.

Original reporting
finimize.com
Published Oct 5, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
McKesson Eyes Option Care Deal With CD&R — source image
Source · finimize.com
Decision brief

The 30-second read

$MCKBullishMed
01

Why it matters

If the deal proceeds, McKesson could expand its specialty pharmacy footprint, while Option Care shareholders may receive a premium.

02

Market read

The rumored $5 billion deal could reshape the healthcare distribution landscape and move both stocks.

03

What to watch

Regulatory approval risk and financing terms could delay or derail the transaction.

Relevance 8/10Novelty 8/10Timing: potential announcement as early as Tuesday

Background

McKesson, a leading drug distributor, is exploring a takeover of Option Care Health, a specialty pharmacy provider, with private‑equity firm CD&R involved.

Company-level read

Ticker impact

$MCKBullishHigh confidence
Context

McKesson is reported to be negotiating a potential $5 billion acquisition of Option Care Health.

Expected impact

likely upside as market prices in acquisition premium expectations

Evidence & confidence

First report of a large‑scale M&A talks; $5 B size is material for both mid‑cap participants.

$OPCHBullishHigh confidence
Context

Option Care Health is the target of a rumored $5 billion acquisition by McKesson.

Expected impact

likely upside driven by acquisition premium expectations

Evidence & confidence

Deal rumors are fresh and sizable, creating immediate pricing pressure on the target.

Market effects

Sector

Consolidation trend in healthcare distribution could pressure peers.

Regional

U.S. healthcare sector may see modest rally on M&A optimism.

Global

Large deal size underscores ongoing consolidation in global pharma supply chains.

Counterpoint

What could challenge this read

Deal could fall apart, causing a sell‑off in both stocks if negotiations stall.

Key entities

  • Company
    McKesson Corporation

    U.S. drug distributor and potential acquirer.

  • Company
    Option Care Health

    Specialty pharmacy services provider and acquisition target.

  • Private Equity
    Clayton, Dubilier & Rice

    Financial sponsor involved in the potential transaction.

Read at source← All news

Also covered by

4 outlets

Related articles

OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

hdfcsky.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min
OCT 6
$OPCHHighAI 9/10

Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid

Option Care Health (OPCH) surged 33% to $31.11 after announcing a $5.8B acquisition by CD&R and McKesson at a 37% premium. The deal, expected to close in 2027, values OPCH at $32.05 per share. The company will delist from Nasdaq. Hedge fund holdings fell 42% QoQ despite more funds establishing positions. Q3 earnings, due Nov 4, 2026, will not include guidance.

finance.yahoo.com2 min